어플

The arrest warrant for Jang Won-jun, former CEO of Shin Poong Pharmaceutical, is dismissed

Business / 폴리 / 01/29/2023 11:55 PM
This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology
(사진=연합뉴스)

[Alpha Biz=(Chicago) Reporter Paul Lee] An arrest warrant for former CEO of Shinpoong Pharmaceutical Co., who was accused of raising slush funds worth 5.7 billion won through false transactions with customers and inflating unit prices, was rejected by the court.

Kim Jung-min, a senior judge in charge of warrants at the Seoul Central District Court, on the 27th rejected the request for former CEO Jang Won-joon's arrest warrant filed by the prosecution on charges of violating the Act on External Audit of Stock Companies, saying, "It is hard to say that there is a fear of destroying evidence."

Former CEO Jang Won-joon is suspected of colluding with Executive Director A of Shinpoong Pharmaceutical to create a slush fund worth 5.7 billion won by returning the difference after a fake transaction with Company B, a pharmaceutical raw material company, from April 2011 to March 2018. It is also suspected of falsely preparing and disclosing Shinpoong Pharmaceutical's financial statements.

Meanwhile, executive director A was first put on trial under arrest last month, and former Shinpoong Pharmaceutical Chairman Jang Yong-taek, who was involved in the allegations, died and was treated as having no right to indict.

 

AlphaBIZ 폴리(hoondork@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS